222 related articles for article (PubMed ID: 29717275)
1. Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers.
Honma M; Sawada S; Ueno Y; Murakami K; Yamada T; Gao J; Kodama S; Izumi T; Takahashi K; Tsukita S; Uno K; Imai J; Kakazu E; Kondo Y; Mizuno K; Kawagishi N; Shimosegawa T; Katagiri H
Int J Obes (Lond); 2018 Sep; 42(9):1544-1555. PubMed ID: 29717275
[TBL] [Abstract][Full Text] [Related]
2. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
3. Imbalanced insulin substrate-1 and insulin substrate-2 signaling trigger hepatic steatosis in vitamin D deficient rats: 8-methoxypsoralen, a vitamin D receptor ligand with a promising anti-steatotic action.
Elhafiz M; Zhao G; Ismail M; Xu D; Das D; Fan S; Cheng N; Yousef BA; Jiang Z; Zhang L
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158657. PubMed ID: 32045698
[TBL] [Abstract][Full Text] [Related]
4. Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease.
Kanuri G; Ladurner R; Skibovskaya J; Spruss A; Königsrainer A; Bischoff SC; Bergheim I
Liver Int; 2015 Feb; 35(2):562-8. PubMed ID: 24351080
[TBL] [Abstract][Full Text] [Related]
5. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.
Xing LJ; Zhang L; Liu T; Hua YQ; Zheng PY; Ji G
Eur J Pharmacol; 2011 Oct; 668(3):467-71. PubMed ID: 21839075
[TBL] [Abstract][Full Text] [Related]
6. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
[TBL] [Abstract][Full Text] [Related]
7. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
8. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
[TBL] [Abstract][Full Text] [Related]
9. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
10. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.
Xu M; Zheng XM; Jiang F; Qiu WQ
J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055
[TBL] [Abstract][Full Text] [Related]
12. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity.
Kubota N; Kubota T; Kajiwara E; Iwamura T; Kumagai H; Watanabe T; Inoue M; Takamoto I; Sasako T; Kumagai K; Kohjima M; Nakamuta M; Moroi M; Sugi K; Noda T; Terauchi Y; Ueki K; Kadowaki T
Nat Commun; 2016 Oct; 7():12977. PubMed ID: 27708333
[TBL] [Abstract][Full Text] [Related]
13. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotective Effect of Loquat Leaf Flavonoids in PM
Jian T; Ding X; Wu Y; Ren B; Li W; Lv H; Chen J
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275422
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein 7 accelerates hepatic steatosis and insulin resistance in non-alcoholic fatty liver disease.
Yan H; Li T; Wang Y; Li H; Xu J; Lu X
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1101-1110. PubMed ID: 31397492
[TBL] [Abstract][Full Text] [Related]
16. Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.
Enooku K; Kondo M; Fujiwara N; Sasako T; Shibahara J; Kado A; Okushin K; Fujinaga H; Tsutsumi T; Nakagomi R; Minami T; Sato M; Nakagawa H; Kondo Y; Asaoka Y; Tateishi R; Ueki K; Ikeda H; Yoshida H; Moriya K; Yotsuyanagi H; Kadowaki T; Fukayama M; Koike K
J Gastroenterol; 2018 Dec; 53(12):1261-1275. PubMed ID: 29749571
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.
Dongiovanni P; Valenti L; Rametta R; Daly AK; Nobili V; Mozzi E; Leathart JB; Pietrobattista A; Burt AD; Maggioni M; Fracanzani AL; Lattuada E; Zappa MA; Roviaro G; Marchesini G; Day CP; Fargion S
Gut; 2010 Feb; 59(2):267-73. PubMed ID: 20176643
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion.
Eriksen PL; Vilstrup H; Rigbolt K; Suppli MP; Sørensen M; Heebøll S; Veidal SS; Knop FK; Thomsen KL
Liver Int; 2019 Nov; 39(11):2094-2101. PubMed ID: 31386258
[TBL] [Abstract][Full Text] [Related]
19. The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitis.
van der Graaff D; Kwanten WJ; Francque SM
Med Hypotheses; 2019 Jan; 122():188-197. PubMed ID: 30593409
[TBL] [Abstract][Full Text] [Related]
20. Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease.
Rodríguez A; Gena P; Méndez-Giménez L; Rosito A; Valentí V; Rotellar F; Sola I; Moncada R; Silva C; Svelto M; Salvador J; Calamita G; Frühbeck G
Int J Obes (Lond); 2014 Sep; 38(9):1213-20. PubMed ID: 24418844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
